Hormone therapy for the management of the menopause in Ecuador: Perception, use and knowledge among middle-aged women

Gynecological Endocrinology

Volumn 24, Issue 10, 2008, Pages 580-585

  Leon Leon, Patricia ^a,b   Chedraui, Peter ^a,c   Hidalgo, Luis ^a,c   Ortiz, Fernando ^c   Castelo Branco, Camil ^d,e  

^a Ecuadorian Climacteric and Menopause Society (SECLIM)   (Ecuador)

^b UNIVERSIDAD DE GUAYAQUIL   (Ecuador)

^c UNIVERSIDAD CATÓLICA DE SANTIAGO DE GUAYAQUIL   (Ecuador)

^d UNIVERSITY OF BARCELONA   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Attitude; Compliance; Hormone therapy; Information; Knowledge; Menopause; Perception

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG USE; ECUADOR; FEMALE; HEALTH BELIEF; HEALTH EDUCATION; HORMONAL THERAPY; HUMAN; LOWEST INCOME GROUP; MEDICAL INFORMATION; MENOPAUSE; PHYSICIAN; PRIORITY JOURNAL; STRUCTURED QUESTIONNAIRE; TELEVISION; TREATMENT DURATION;

ADULT; AGE FACTORS; AGED; DATA COLLECTION; ECUADOR; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MENOPAUSE; MIDDLE AGED; PATIENT COMPLIANCE; PERCEPTION; SOCIOECONOMIC FACTORS;

EID: 56549096878     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802288234     Document Type: Article

References (46)

1. Castelo-Branco C, Rostro F. Management of menopause. Minerva Ginecol 2006;58:137-152.
2. Castelo-Branco C, Palacios S, Calaf J, Vazquez F, Lanchares JL. Available medical choices for the management of menopause. Maturitas 2005;52(Suppl 1): S61-S70.
3. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Julia MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52(Suppl 1): S46-S52.
4. Blumel JE, Castelo-Branco C, Leal T, Gallardo L, Saini J, Ferron S, Haya J. Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease. Climacteric 2003;6:38-44.
5. Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martinez de Osaba MJ, Casals E, Pons F, Balasch J, Vanrell JA. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 2000;34:161-168.
6. Castelo-Branco C, Duran M, Puig M, Vanrell JA. Compliance with hormone replacement therapy at the menopause. J Obstet Gynaecol 1995;15:204-205.
7. Castelo-Branco C, Figueras F, Sanjuan A, Vicente JJ, Martinez de Osaba MJ, Pons F, Balasch J, Vanrell JA. Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. Menopause 1999;6:307-311.
8. Blumel JE, Castelo-Branco C, Riquelme R, Araya H, Jaramillo P, Tacla X, Colodrón M, Lavín P. Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels. Menopause 2002;9:377-380.
9. Bianco V, Murina F, Roberti P, Valente I. Tibolone in the treatment of menopause: compliance, efficacy and safety in a ten year experience. Minerva Ginecol 2006;58:335-344.
10. Castelo-Branco C, Peralta S, Ferrer J, Palacios S, Cornago S, Quereda F. The dilemma of menopause and hormone replacement - a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women. Climacteric 2006;9:380-387.
11. Castelo-Branco C, Ferrer J, Palacios S, Cornago S, Peralta S. Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas 2007;56:420-428.
12. Hara Y, Shintani M. [Compliance of hormone replacement therapy in postmenopausal women in Japan]. Nippon Rinsho 2004;62(Suppl 2): 496-500.
13. Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy. A survey of women's knowledge and attitudes. Arch Intern Med 1989;149:133-136.
14. Corrado F, D'Anna R, Caputo F, Cannata ML, Zoccali MG, Cancellieri F. Compliance with hormone replacement therapy in postmenopausal Sicilian women. Eur J Obstet Gynecol Reprod Biol 2005;118:225-228.
15. Wattanakumtornkul S, Chichareon S, Geater A, Suwan K. Compliance with hormone replacement therapy at Songklanagarind Hospital. J Obstet Gynaecol Res 2003;29:380-387.
16. Yasui T, Uemura H, Takikawa M, Irahara M. Hormone replacement therapy in postmenopausal women. J Med Invest 2003;50:136-145.
17. Shmuely Y, Berlin JA, Knauss J, Lydick E. Compliance with oral HRT in postmenopausal women in clinical trials - meta analysis. Maturitas 2003;46:33-44.
18. Lindh-Astrand L, Brynhildsen J, Hoffmann M, Liffner S, Hammar M. Attitudes towards the menopause and hormone therapy over the turn of the century. Maturitas 2007;56:12-20.
19. Ekstrom H. Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it. Maturitas 2005;52:154-164.
20. Blumel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gomez MS, Sarra S. Patients' and clinicians' attitudes after the Women's Health Initiative study. Menopause 2004;11:57-61.
21. Lazar F, Jr., Costa-Paiva L, Morais SS, Pedro AO, Pinto-Neto AM. The attitude of gynecologists in Sao Paulo, Brazil 3 years after the Women's Health Initiative study. Maturitas 2007;56:129-141.
22. Travers C, O'Neill SM, Khoo SK, King R. Hormones down under: hormone therapy use after the Women's Health Initiative. Aust N Z J Obstet Gynaecol 2006;46:330-335.
23. Gerend MA, Aiken LS, Erchull MJ, Lapin A. Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change. Prev Med 2006;43:158-164.
24. Power ML, Zinberg S, Schulkin J. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy. Menopause 2006;13:434-441.
25. Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study. Menopause 2006;13:125-129.
26. Hoffmann M, Hammar M, Kjellgren KI, Lindh-Astrand L, Brynhildsen J. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI. Maturitas 2005;52:11-17.
27. Longworth JC. Hispanic women's experience with 'el cambio de vida'. J Am Acad Nurs Pract 2003;15:266-275.
28. Castelo-Branco C, Blumel JE, Chedraui P, Calle A, Bocanera R, Depiano E, Figueroa-Casas P, Gonzalez C, Martino M, Royer M, et al. Age at menopause in Latin America. Menopause 2006;13:706-712.
29. Leon P, Chedraui P, Hidalgo L, Ortiz F. Perceptions and attitudes toward the menopause among middle aged women from Guayaquil, Ecuador. Maturitas 2007;57:233-238.
30. Hvas L. Menopausal women's positive experience of growing older. Maturitas 2006;54:245-251.
31. Kowalcek I, Rotte D, Banz C, Diedrich K. Women's attitude and perceptions towards menopause in different cultures. Cross-cultural and intra-cultural comparison of premenopausal and post-menopausal women in Germany and in Papua New Guinea. Maturitas 2005;51:227-235.
32. Melby MK, Lock M, Kaufert P. Culture and symptom reporting at menopause. Hum Reprod Update 2005;11:495-512.
33. Lock M. Symptom reporting at menopause: a review of cross-cultural findings. J Br Menopause Soc 2002;8:132-136.
34. Gavin NI, Thorp JM, Ohsfeldt RL. Determinants of hormone replacement therapy duration among postmenopausal women with intact uteri. Menopause 2001;8:377-383.
35. Sturdee DW. The importance of patient education in improving compliance. Climacteric 2000;3(Suppl 2): 9-13.
36. Eiken P, Kolthoff N. Compliance with 10 years oral hormonal replacement therapy. Maturitas 2002;41:81-86.
37. Beral V, Banks E, Reeves G, Appleby P. Use of HRT and the subsequent risk of cancer. J Epidemiol Biostat 1999;4:191-210.
38. Armstrong K, Popik S, Guerra C, Ubel PA. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy. Med Decis Making 2000;20:308-313.
39. Castelo-Branco C, Ferrer J, Palacios S, Cornago S. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists. Maturitas 2006;55:308-316.
40. Carney PA, Tosteson AN, Titus-Ernstoff L, Weiss JE, Goodrich ME, Manganiello P, Kasales CJ. Hormone therapies in women aged 40 and older: prevalence and correlates of use. Maturitas 2006;53:65-76.
41. Olesen AV, Johnsen SP, Mortensen JT, Boggild H, Olsen J, Sorensen HT. Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women. Acta Obstet Gynecol Scand 2005;84:639-644.
42. Donker GA, Spreeuwenberg P, Bartelds AI, van der Velden K, Foets M. Hormone replacement therapy: changes in frequency and type of prescription by Dutch GPs during the last decade of the millennium. Fam Pract 2000;17:508-513.
43. Jolleys JV, Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas 1996;23:47-53.
44. Bermejo MJ, Perez IR. Physicians and the prescription of hormone replacement therapy in Spain. Health Policy 2005;73:58-65.
45. Roberson NL. Clinical trial participation. Viewpoints from racial/ethnic groups. Cancer 1994;74:2687-2691.
46. Safran DG, Taira DA, Rogers WH, Kosinski M, Ware JE, Tarlov AR. Linking primary care performance to outcomes of care. J Fam Pract 1998;47:213-220.